Tatsuya Takayama

Summary

Affiliation: Hamamatsu University School of Medicine
Country: Japan

Publications

  1. pmc Use of three-dimensional time-resolved phase-contrast magnetic resonance imaging with vastly undersampled isotropic projection reconstruction to assess renal blood flow in a renal cell carcinoma patient treated with sunitinib: a case report
    Tatsuya Takayama
    Departments of Urology, Hamamatsu University School of Medicine, 1 20 1 Higashi ku, Handayama, Hamamatsu, Shizuoka 431 3192, Japan
    BMC Res Notes 7:527. 2014
  2. ncbi [Salvage therapy for castration-refractory prostate cancer resistant to docetaxel]
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine
    Nihon Hinyokika Gakkai Zasshi 104:681-7. 2013
  3. ncbi Axitinib controlled metastatic renal cell carcinoma for 5 years
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Higashi ku, Handayama, Hamamatsu, Shizuoka 431 3192, Japan
    Jpn J Clin Oncol 43:747-51. 2013
  4. doi Temsirolimus controlled metastatic advanced renal cell carcinoma for over 4 years: a case study
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Higashi ku, Handayama, Hamamatsu, Shizuoka 431 3192, Japan
    Med Oncol 30:563. 2013
  5. pmc A novel mutation in the GRHPR gene in a Japanese patient with primary hyperoxaluria type 2
    Tatsuya Takayama
    Department of Cancer Biology, Wake Forest University School of Medicine, Medical Center Blvd, Winston Salem, NC 27157, USA
    Nephrol Dial Transplant 22:2371-4. 2007
  6. doi BK virus nephropathy: clinical experience in a university hospital in Japan
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Handayama, Higashi ku, Hamamatsu, Shizuoka 431 3192, Japan
    Int J Urol 16:924-8. 2009
  7. doi Should ipsilateral solitary adrenal involvement in renal cell carcinoma be staged as M1?
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Handayama, Hamamatsu, Shizuoka 431 3192, Japan
    Jpn J Clin Oncol 41:792-6. 2011
  8. doi Characteristics of aggressive variants in T1a renal cell carcinoma
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Handayama, Hamamatsu, Shizuoka 431 3192, Japan
    J Cancer Res Clin Oncol 137:1653-9. 2011
  9. ncbi High levels of thymidine phosphorylase as an independent prognostic factor in renal cell carcinoma
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, Shizuoka 431 3192, Japan
    Jpn J Clin Oncol 36:564-9. 2006
  10. ncbi BK virus subtype IV nephropathy occurring 5 years after kidney transplantation
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Handayama, Hamamatsu, Shizuoka 431 3192, Japan
    Clin Exp Nephrol 11:102-6. 2007

Detail Information

Publications43

  1. pmc Use of three-dimensional time-resolved phase-contrast magnetic resonance imaging with vastly undersampled isotropic projection reconstruction to assess renal blood flow in a renal cell carcinoma patient treated with sunitinib: a case report
    Tatsuya Takayama
    Departments of Urology, Hamamatsu University School of Medicine, 1 20 1 Higashi ku, Handayama, Hamamatsu, Shizuoka 431 3192, Japan
    BMC Res Notes 7:527. 2014
    ....
  2. ncbi [Salvage therapy for castration-refractory prostate cancer resistant to docetaxel]
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine
    Nihon Hinyokika Gakkai Zasshi 104:681-7. 2013
    ..To evaluate the treatment for castration-refractory prostate cancer (CRPC) resistant to docetaxel..
  3. ncbi Axitinib controlled metastatic renal cell carcinoma for 5 years
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Higashi ku, Handayama, Hamamatsu, Shizuoka 431 3192, Japan
    Jpn J Clin Oncol 43:747-51. 2013
    ..To get a long-term response to axitinib, it may be important to control well the balance between treatment effect and adverse events while using drug withdrawal. ..
  4. doi Temsirolimus controlled metastatic advanced renal cell carcinoma for over 4 years: a case study
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Higashi ku, Handayama, Hamamatsu, Shizuoka 431 3192, Japan
    Med Oncol 30:563. 2013
    ..He died of progressive COPD and latent interstitial pneumonia 4 months after discontinuing temsirolimus. To our knowledge, he lived the longest in East Asian populations since starting temsirolimus...
  5. pmc A novel mutation in the GRHPR gene in a Japanese patient with primary hyperoxaluria type 2
    Tatsuya Takayama
    Department of Cancer Biology, Wake Forest University School of Medicine, Medical Center Blvd, Winston Salem, NC 27157, USA
    Nephrol Dial Transplant 22:2371-4. 2007
  6. doi BK virus nephropathy: clinical experience in a university hospital in Japan
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Handayama, Higashi ku, Hamamatsu, Shizuoka 431 3192, Japan
    Int J Urol 16:924-8. 2009
    ..To review the medical records of patients with BK virus nephropathy (BKVN) following kidney transplantation in our institution...
  7. doi Should ipsilateral solitary adrenal involvement in renal cell carcinoma be staged as M1?
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Handayama, Hamamatsu, Shizuoka 431 3192, Japan
    Jpn J Clin Oncol 41:792-6. 2011
    ..To date, however, the staging of ipsilateral solitary adrenal involvement in renal cell carcinoma has not been sufficiently evaluated...
  8. doi Characteristics of aggressive variants in T1a renal cell carcinoma
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Handayama, Hamamatsu, Shizuoka 431 3192, Japan
    J Cancer Res Clin Oncol 137:1653-9. 2011
    ..To explore factors associated with metastasis and prognosis in T1a renal cell carcinoma (RCC)...
  9. ncbi High levels of thymidine phosphorylase as an independent prognostic factor in renal cell carcinoma
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, Shizuoka 431 3192, Japan
    Jpn J Clin Oncol 36:564-9. 2006
    ..We investigated whether thymidine phosphorylase (TP) protein level in renal cell carcinoma (RCC) correlates with clinicopathological characteristics and clinical outcomes...
  10. ncbi BK virus subtype IV nephropathy occurring 5 years after kidney transplantation
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Handayama, Hamamatsu, Shizuoka 431 3192, Japan
    Clin Exp Nephrol 11:102-6. 2007
    ..The progress of the disease was monitored by quantitative real-time polymerase chain reactions for BK virus DNA. An analysis of viral DNA showed that the BK virus in the patient's plasma belonged to genotype IV...
  11. ncbi Long-term outcome of a low-dose intravesical bacillus Calmette-Guerin therapy for carcinoma in situ of the bladder: results after six successive instillations of 40 mg BCG
    Soichi Mugiya
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Handayama, Hamamatsu 431 3192, Japan
    Jpn J Clin Oncol 35:395-9. 2005
    ..We employed a dose of 40 mg once a week for six consecutive weeks in principle for carcinoma in situ (CIS) of the bladder, and retrospectively evaluated its effectiveness and safety...
  12. doi Impact of thymidine phosphorylase-expressing macrophages for surgical margin in partial nephrectomy
    Hongming Liu
    Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Urol Int 82:388-93. 2009
    ..We investigated the relationship between the surgical margin in partial nephrectomy (PN) and thymidine phosphorylase (TP)-expressing macrophages in peritumoral tissue of renal cell carcinoma (RCC)...
  13. ncbi Thymidine phosphorylase and dihydropyrimidine dehydrogenase in renal cell carcinoma: relationship between histological parameters and chemosensitivity to 5-fluorouracil
    Yasuhiro Hirano
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Handayama, Hamamatsu 431 3192, Japan
    Eur Urol 43:45-51; discussion 51-2. 2003
    ..In addition, the results of in vitro chemosensitivity testing were also analyzed to determine whether TdR-Pase and/or DPD activity in carcinoma cells can predict the efficacy of 5-FU...
  14. ncbi [Bilateral adrenal hemorrhage due to adrenal metastasis of lung cancer]
    Keita Tamura
    Department of Urology, Hamamatsu University School of Medicine
    Nihon Hinyokika Gakkai Zasshi 104:17-21. 2013
    ..However, prognosis for this mortal condition may be improved should patients receive adrenalectomy followed by an appropriate treatment regimen...
  15. ncbi BK virus subtype 1 infection associated with tubulointerstitial nephritis in a renal allograft recipient
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431 3912, Japan
    Int J Urol 11:656-62. 2004
    ..We also determined that BKV belonged to genotype I by analysis of viral DNA from the patient's urine...
  16. doi Combination therapy with sorafenib and S-1 for renal cell carcinoma producing granulocyte colony-stimulating factor
    Yoko Kyono
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Higashi ku, Handayama, Hamamatsu, Shizuoka 431 3192, Japan
    Int J Clin Oncol 16:275-8. 2011
    ..The use of combined sorafenib and S-1 may be worthy of consideration in the treatment of RCC producing G-CSF...
  17. ncbi Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma
    Takumi Teratani
    Laboratory of Host Defenses, University of Shizuoka Graduate School of Health Science, Suruga ku, Shizuoka, Japan
    Urology 69:236-40. 2007
    ..To clarify the gene expression patterns of fatty acid-binding protein (FABP) and evaluate it as a potential marker for the diagnosis of renal cell carcinoma (RCC). RCC is the most common renal neoplasm...
  18. ncbi [A case of proliferative cystitis forming ureterovesical junction obstruction]
    Takahisa Suzuki
    The Department of Urology, Hamamatsu University School of Medicine, Japan
    Hinyokika Kiyo 57:573-6. 2011
    ..One year after the last operation, there is no evidence of recurrence of the tumor. Tumor formation arising from proliferative cystitis is relatively rare. Pathogenesis and management of this rare condition are discussed...
  19. ncbi Primary hyperoxaluria type 1 in Japan
    Tatsuya Takayama
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Handayama, Hamamatsu, Shizuoka, Japan
    Am J Nephrol 25:297-302. 2005
    ..Current status of primary hyperoxaluria (PH) has not been surveyed in Japan...
  20. ncbi Ureteroscopic evaluation and laser treatment of chronic unilateral hematuria
    Soichi Mugiya
    Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    J Urol 178:517-20. 2007
    ..We evaluated patients with unilateral renal hematuria to determine the cause of bleeding and investigated the usefulness of ureteroscopic laser treatment for this condition...
  21. ncbi Retrograde endoscopic laser therapy and ureteroscopic surveillance for transitional cell carcinoma of the upper urinary tract
    Soichi Mugiya
    Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Int J Urol 13:1-6. 2006
    ..To investigate the efficacy of endoscopic laser therapy and ureteroscopic surveillance for transitional cell carcinoma (TCC) of the upper urinary tract...
  22. ncbi Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation
    Takafumi Naito
    Division of Hospital Pharmacy, Hamamatsu University School of Medicine, 1 20 1 Handa yama, Hamamatsu 431 3192, Japan
    Biol Pharm Bull 29:275-80. 2006
    ..We indicate that it may be necessary to estimate biliary excretion of MPAG to avoid the risk of intestinal injury in patients receiving combination therapy with TAC during the maintenance period...
  23. doi Efficacy of adjuvant interferon-alpha therapy following curative resection in renal cell carcinoma: before the molecular targeting therapy era
    Fumitake Kai
    Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan
    Jpn J Clin Oncol 39:310-4. 2009
    ..Although present treatment programs for renal cell carcinoma (RCC) typically involve molecular-targeting drugs, interferon-alpha (IFN-alpha) remains an important therapeutic drug for this cancer...
  24. doi Natural history of renal cell carcinoma: a case with 18 years follow-up
    Fumitake Kai
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Higashi ku, Handayama, Hamamatsu, Shizuoka 431 3192, Japan
    Clin Exp Nephrol 15:312-5. 2011
    ..It is necessary to clarify the course that RCC takes due to its unpredictable, indolent nature. This will provide clinicians with better insight into how to manage the disease, decide on treatment options, and improve overall survival...
  25. doi Impact of CYP3A5 genetic polymorphism on cross-reactivity in tacrolimus chemiluminescent immunoassay in kidney transplant recipients
    Kumi Hirano
    Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1 20 1 Handayama, Higashi ku, Hamamatsu, Shizuoka 431 3192, Japan
    Clin Chim Acta 414:120-4. 2012
    ..The aim of this study was to evaluate the cross-reactivity in tacrolimus chemiluminescent immunoassay (CLIA) in kidney transplant recipients and to characterize the cross-reactivity according to CYP3A5 genetic polymorphism...
  26. ncbi Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma
    Tomohiro Domoto
    Laboratory of Host Defense, University of Shizuoka, Shizuoka, Japan
    Cancer Sci 98:77-82. 2007
    ..It was found that all three performed well as RCC markers. B-FABP was most specific to RCC, as it was expressed little in normal kidney tissues...
  27. ncbi [Economical aspects on the treatments of urolithiasis by surgical methods: comparison of surgical method selections and world status]
    Shinji Kageyama
    Department of Urology, Hamamatsu University School of Medicine
    Hinyokika Kiyo 50:587-90. 2004
    ..Furthermore, we clarified the cost of these methods. Based on the status of world countries, we demonstrate the ideal selection including economical aspects on the selection of endourological method...
  28. ncbi Assay of alanine:glyoxylate aminotransferase in human liver by its serine: glyoxylate aminotransferase activity
    Masao Nagata
    Department of Urology, Hamamatsu University School of Medicine, Higashi ku, Hamamatsu, Shizuoka, Japan
    Biomed Res 30:295-301. 2009
    ..There was a combined good correlation between the AGT, SGT and SPT activities, and the activity ratio, AGT : SGT : SPT was about 1.0 : 0.17 : 0.13...
  29. pmc Analysis of the regulation of fatty acid binding protein 7 expression in human renal carcinoma cell lines
    Naohisa Takaoka
    Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan
    BMC Mol Biol 12:31. 2011
    ..The abundant expression of FABP7 in primary RCCs compared to certain RCC-derived cell lines may allow the definition of the molecular components of FABP7's regulatory system...
  30. doi Inappropriate elevation of serum thyrotropin levels in patients treated with axitinib
    Kenji Ohba
    Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan
    Thyroid 23:443-8. 2013
    ..Although anticancer treatment with the tyrosine kinase inhibitor (TKI) axitinib frequently causes thyroid dysfunction, the associated mechanism and clinical features have not been elucidated...
  31. doi Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases: a multicenter study of 556 patients
    Sei Naito
    Department of Urology, Yamagata University Faculty of Medicine, Yamagata, Japan
    Urology 82:846-51. 2013
    ..To investigate the prognosis and prognostic factors of patients with metastatic renal cell carcinoma who underwent metastasectomy...
  32. pmc Hydroxyproline metabolism in mouse models of primary hyperoxaluria
    John Knight
    Dept of Urology, Wake Forest Univ Health Sciences, Winston Salem, NC 27157, USA
    Am J Physiol Renal Physiol 302:F688-93. 2012
    ..As Hyp catabolism may make a major contribution to the oxalate produced in PH patients, Hyp feeding in these mouse models should be useful in understanding the mechanisms associated with calcium oxalate deposition in the kidney...
  33. doi Modification of primers for GRHPR genotyping: avoiding allele dropout by single nucleotide polymorphisms and homology sequence
    Naohisa Takaoka
    Department of Urology, Hamamatsu University School of Medicine, 1 20 1 Handayama, Higashi ku, Hamamatsu, Shizuoka, 431 3192, Japan
    Urol Res 36:297-302. 2008
    ..Using this technique, we sequenced four common SNPs between intron E and exon 6, which show linkage disequilibrium (LD) consisting of three types of haplotypes, similar to data from the HapMap SNP database...
  34. doi Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients
    Sei Naito
    Department of Urology, Yamagata University, Yamagata 951 8510, Japan
    Eur Urol 57:317-25. 2010
    ..Clinical studies of risk factors in patients with metastatic RCC (mRCC) are mainly based on data from non-Asian patients...
  35. ncbi Retrograde endoscopic management of ureteral stones more than 2 cm in size
    Soichi Mugiya
    Department of Urology, Hamamatsu University School of Medicine, Handayama, Hamamatsu, Japan
    Urology 67:1164-8; discussion 1168. 2006
    ..To verify the safety and efficacy of retrograde endoscopic lithotripsy as the treatment modality for large ureteral stones...
  36. doi Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma
    Hirotaka Fukasawa
    First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan
    Int J Cancer 127:1517-25. 2010
    ..Our results suggest that the low TbetaR-II protein level is due to augmented ubiquitin-dependent degradation via Smurf2 and might be involved in the attenuation of TGF-beta signaling pathway in RCC...
  37. ncbi [Intravesical Bacillus Calmette-Guerin (BCG: Tokyo 172 strain) instillation for carcinoma in situ of the bladder: results with 6 successive instillations of 40 mg BCG]
    Soichi Mugiya
    Department of Urology, Hamamatsu University School of Medicine
    Hinyokika Kiyo 50:469-73. 2004
    ..These results indicate that intravesical instillation of BCG at a dose of 40 mg given 6 times was as effective as the routine dose of 80 mg, and could decrease systemic adverse effects such as high fever...
  38. ncbi Risk factors for ipsilateral adrenal involvement in renal cell carcinoma
    Keiichi Ito
    Department of Urology, National Defense Medical College, Tokorozawa, Japan
    Urology 72:354-8. 2008
    ..We retrospectively review patients treated for renal cell carcinoma at 19 institutes in collaboration with the Japanese Society of Renal Cancer, to clarify the risk factors for ipsilateral adrenal involvement (IADI)...
  39. ncbi [Novel molecular-targeted drug for renal cancer(AXIS trial)]
    Seiichiro Ozono
    Dept of Urology, Hamamatsu University School of Medicine, Japan
    Gan To Kagaku Ryoho 40:26-9. 2013
    ..The present manuscript summarizes this new drug and the AXIS trial...
  40. doi [Pharmacotherapy for preventing calcium containing stone formation]
    Masao Nagata
    Department of Urology, Hamamatsu University School of Medicine, Japan
    Clin Calcium 21:1530-4. 2011
    ..Recent new drugs and the elucidation of new metabolic pathways may lead to the development of prevention of urolithiasis...
  41. ncbi Control of oxalate formation from L-hydroxyproline in liver mitochondria
    Tatsuya Takayama
    Department of Urology, Research Equipment Center, Hamamatsu University School of Medicine, Hamamatsu, Japan
    J Am Soc Nephrol 14:939-46. 2003
    ....
  42. ncbi Thymidine phosphorylase activity in renal cell carcinoma: relationship between histological parameters and chemosensitivity to fluorouracil-related drugs
    Yasuhiro Hirano
    Department of Urology, Hamamatsu University School of Medicine, Handayama Hamamatsu City, Japan
    Urol Res 30:112-5. 2002
    ..High TdR-Pase activity in human RCC was confirmed to predict high tumor grade and stage. RCCs with high TdR-Pase activity were also sensitive to FU-related drugs...
  43. ncbi [Interferon-based cytokine therapy for advanced renal cell carcinoma]
    Tatsuya Takayama
    The Department of Urology, Hamamatsu University School of Medicine
    Hinyokika Kiyo 51:499-502. 2005
    ..3%, respectively. The style of treatment did not influenced survival in these patients. Therefore, an accurate assessment of their survival benefits both them and physician while it is urgent that we develop novel agents and strategy...